Average one-year price target for X4 Pharmaceuticals (XFOR) was revised to $11.90, a 25.00% increase from the prior $9.52 target dated Feb 21, 2026. The figure represents an average of analysts' targets (article truncated before listing contributors); no company results or guidance were reported. This is an analyst-driven upward revision that may modestly boost sentiment in the stock but is unlikely to have broader market impact.
Average one-year price target for X4 Pharmaceuticals (XFOR) was revised to $11.90, a 25.00% increase from the prior $9.52 target dated Feb 21, 2026. The figure represents an average of analysts' targets (article truncated before listing contributors); no company results or guidance were reported. This is an analyst-driven upward revision that may modestly boost sentiment in the stock but is unlikely to have broader market impact.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.30
Ticker Sentiment
